Chloroquine Phosphate 5MLml vials are designed for intramuscular or subcutaneous injection, primarily for treating severe malaria, with a typical strength of base/mL (or sometimes phosphate equivalent per mL). These, such as Lariago, are prescription-only, liquid-form, multi-dose glass vials often containing benzyl alcohol as a preservative.
Key Specifications & Details:
Active Ingredient: Chloroquine Phosphate BP/USP.
Concentration: base/mL ( per vial total).
Form: Liquid solution for injection (intramuscular/subcutaneous).
Packaging:
glass vial, often in multi-dose, with preservatives.
Common Brand/Manufacturer: Lariago (Ipca Laboratories), Syncom
Formulations.
Indications: Treatment of malaria, amoebiasis, and sometimes, acute arthritis.
Storage: Typically stored in a cool, dry place, protected from direct sunlight.
Shelf Life: Approximately months. Composition (Typical):Chloroquine Phosphate:
(equivalent to Chloroquine base).Preservative: Benzyl Alcohol BP Vehicle: Water
for Injection.
Physical Form
Liquid
Recommended For
HUMAN BEING
Dosage
As Per Suggestion
Quantity
10000 Unit
About CHLOROQUINE INJ 5ML
Chloroquine Phosphate Injection (40mg/mL) in 5ml ampoules is a sterile, parenteral antimalarial agent used for treating acute or severe malaria when oral therapy is not possible. It acts by inhibiting heme polymerase, and is administered via intramuscular or slow intravenous infusion. It is also used to treat hepatic amoebiasis.
Key Information regarding 40mg/mL, 5ml Ampoules:
Indications: Treatment of acute malaria caused by P. falciparum, P. malariae, P. vivax, and P. ovale.
Administration: Must be administered slowly (IV) or by deep intramuscular injection. Rapid IV injection can cause severe hypotension or cardiac arrest.
Dosage Information: Often provided as a 5ml ampoule (containing 200mg base) which is typically diluted for use.
Side Effects: Common adverse effects include pruritus (itching), headache, visual disturbances, and gastrointestinal issues.
Contraindications/Precautions: Use with caution in patients with hepatic impairment, renal impairment, or porphyria. It is important to monitor cardiac function (ECG) during parenteral administration.
Tell us about your requirement
Price:
Quantity
Select Unit
50
100
200
250
500
1000+
Additional detail
Mobile number
Email
Name
Comapny Name
Phone Number
Email Id
City / State
Confirm Your Requirement
Verification Code
Did not receive yet?
Resend OTP
You’re Done!
We have received your requirements and will reply shortly with the best price.
Products You May Like
More Products in Pharmaceutical Injection Category